Griffiths Richard Ian bought SLN

August 10, 2026 · Form 4 insider transaction

Griffiths Richard Ian bought 2,792,826 shares of Silence Therapeutics plc, a transaction worth N/A. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 3 days after the transaction.

Direction
Acquired (buy-side)
Shares
2,792,826
Price
N/A
Total value
N/A
Role
SecurityAmerican Depositary Shares
Transaction codeS: Open-market sale
Transaction dateAugust 10, 2026
Filing dateAugust 13, 2026
Shares owned after7,488,660
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

Each American Depositary Share ("ADS") is immediately convertible into three ordinary shares for no consideration and has no expiration date.; The securities were sold by Cream Capital Limited ("CCL"), Blake Holdings Limited ("BHL"), Ora Ventures Limited ("OVL"), Ora Capital Limited ("OCL), Sarossa Plc ("SAR"), Pinkeys Limited ("PKL") and Mr. Griffiths personally. Mr Griffiths is a director and the controlling shareholder of CCL, BHL, OVL and OCL and the controlling shareholder of SAR and PKL. Mr. Griffiths disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein.

View the original Form 4 on SEC EDGAR